600161 天壇生物
按盤價 
16.180 -0.070 (-0.431%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 7.244 | 14.781 | 11.923 | 10.458 | 12.092 |
| 總資產報酬率 ROA (%) | 5.050 | 10.308 | 8.186 | 7.189 | 7.950 |
| 投入資產回報率 ROIC (%) | 6.993 | 14.192 | 11.165 | 9.613 | 10.602 | 邊際利潤分析 |
| 銷售毛利率 (%) | 43.813 | 54.700 | 50.762 | 49.076 | 47.529 |
| 營業利潤率 (%) | 30.331 | 42.405 | 34.842 | 33.607 | 30.274 |
| 息稅前利潤/營業總收入 (%) | 30.178 | 41.684 | 33.763 | 32.109 | 28.619 |
| 淨利潤/營業總收入 (%) | 25.094 | 35.018 | 29.138 | 28.270 | 25.992 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 100.509 | 98.703 | 97.336 | 94.969 | 99.832 |
| 價值變動淨收益/利潤總額(%) | 1.922 | 2.510 | 2.069 | 1.972 | 0.967 |
| 營業外收支淨額/利潤總額(%) | -0.511 | -0.415 | -0.356 | -0.410 | -0.313 | 償債能力分析 |
| 流動比率 (X) | 6.014 | 6.893 | 5.915 | 6.282 | 9.321 |
| 速動比率 (X) | 3.081 | 3.439 | 3.692 | 4.267 | 6.672 |
| 資產負債率 (%) | 9.690 | 8.421 | 10.105 | 12.171 | 11.322 |
| 帶息債務/全部投入資本 (%) | 2.081 | 1.048 | 3.661 | 5.967 | 6.975 |
| 股東權益/帶息債務 (%) | 4,614.208 | 9,261.163 | 2,590.586 | 1,547.292 | 1,311.709 |
| 股東權益/負債合計 (%) | 714.730 | 833.533 | 685.127 | 558.916 | 614.298 |
| 利息保障倍數 (X) | 22,984.695 | -76.390 | -35.317 | -23.595 | -18.346 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 40.013 | 6.591 | 1.777 | 1.820 | 0.969 |
| 存貨周轉天數 (天) | 425.302 | 442.258 | 365.297 | 371.289 | 360.057 |
| 備註： | 即時報價更新時間為 16/12/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
